methylprednisolone acetate has been researched along with Briquet Syndrome in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habib, G | 1 |
| Elias, S | 1 |
| Abu-Elhaija, M | 1 |
| Sakas, F | 1 |
| Khazin, F | 1 |
| Artul, S | 1 |
| Jabbour, A | 1 |
| Jabaly-Habib, H | 1 |
1 other study available for methylprednisolone acetate and Briquet Syndrome
| Article | Year |
|---|---|
The effect of local injection of methylprednisolone acetate on the hypothalamic-pituitary-adrenal axis among patients with greater trochanteric pain syndrome.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Female; Femur; Humans; Hydrocortisone; Hypothala | 2017 |